Certara stock.

1.53. +0.02. +1.66%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 10 Des 2020 ... (Reuters) -U.S. drug development consultancy Certara Inc said on Thursday it sold shares in its initial public offering at $23 apiece, ...Why Certara. Responsibility. Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. Regulatory Adoption. Many global regulatory agencies have adopted use of Certara’s Simcyp PBPK and Phoenix PK/PD platforms. Locations. Discover our global office locations. LeadershipCertara Inc’s (CERT) price is currently up 7.73% so far this month. During the month of March, Certara Inc’s stock price has reached a high of $22.02 and a low of $18.20. Over the last year, Certara Inc has hit prices as high as $24.66 and as low as $10.60. Year to date, Certara Inc’s stock is down 31.32%.Certara is the leading provider of mechanistic modeling software and consulting services, predicting outcomes for the global biopharm industry. The groundbreaking Simcyp Simulator is relied upon by pharmaceutical and biotech companies, academia and regulatory agencies, including the US FDA. Simcyp is committed to using technology and innovation ...

Insiders trading at Certara. Over the last 4 years, insiders at Certara have traded over $2,047,095,989 worth of Certara stock and bought 97,245 units worth $1,908,085 . The most active insiders traders include Avatar Parent L.P.Eqt Avata..., James E Iii Cashman, and Mason P Slaine.On average, Certara executives and independent …GOEV | Complete Canoo Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find the latest Nerdy, Inc. (NRDY) stock quote, history, news and other vital information to help you with your stock trading and investing.

Mar 1, 2023 · Certara Reports Fourth Quarter and Full Year 2022 Financial Results. Annual Revenue Grows 17% on a Reported Basis and 20% at Constant Currency. PRINCETON, N.J.— March 1, 2023– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter and full year of 2022 and issued guidance ...

16 Des 2020 ... Certara today announced that it closed its upsized initial public offering of 33413250 shares of common stock at $23.00 per share.PRINCETON, NJ.—. December 3, 2020 – Certara, Inc. (“Certara”) today announced the launch of its initial public offering of 24,390,000 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 14,630,000 shares of common stock and certain selling ...A description of the common stock (the “Common Stock”) of Certara, Inc. (the “Registrant”) will be contained in a prospectus, constituting part of the Registrant’s Registration Statement on Form S-1 (File No. 333-250182) relating to the Common Stock, to be filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended (such prospectus as filed …Or log in with. Google TwitterCertara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.

Certara, which supplies biosimulation software for customers, undermined investor confidence when it sold 10 million shares for $31. Conversely, Schrödinger made inducement grants of only 7,250 ...

The average twelve-month price prediction for Palantir Technologies is $13.25 with a high price target of $25.00 and a low price target of $5.00. Learn more on PLTR's analyst rating history. Do Wall Street analysts like Palantir Technologies more than its competitors? Analysts like Palantir Technologies less than other Business Services …

Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Certara Inc Registered Shs Aktie Profil Die Certara Inc Registered Shs Aktie wird unter der ISIN US15687V1098 an den Börsen Hamburg, Berlin, NASDAQ, Bats, NASDAQ Bsc, Tradegate und Lang & Schwarz ... Certara ( CERT -1.83%), which provides software and technology to help pharmaceutical companies and researchers accelerate drug development, saw its shares rise 37.7% this week. The stock closed ...The estimated Net Worth of William F Feehery is at least $68.6 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $35,387,994 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.The estimated Net Worth of Richard M. Traynor is at least $10.2 Million dollars as of 6 March 2023. Mr Traynor owns over 10,000 units of Certara stock worth over $4,562,422 and over the last 2 years he sold CERT stock worth over $5,603,360.Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.Oct 11, 2023 · PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023.

View the latest Certara Inc. (CERT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Latest Software and Docebo Inc, Certara Inc Stock News. As of December 1, 2023, Docebo Inc had a $1.9 billion market capitalization, compared to the Software median of $398.3 million. Docebo Inc’s stock is NA in 2023, NA in the previous five trading days and up 41.82% in the past year. Currently, Docebo Inc does not have a price-earnings ratio.Certara Inc stock performance at a glance. Check Certara Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.11 Okt 2023 ... 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial ...1.34%. $25.98M. Plains All American Pipeline L.P. 1.86%. $10.93B. TELL | Complete Tellurian Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find real-time CERT - Certara Inc stock quotes, company profile, news and forecasts from CNN Business.

11 Okt 2023 ... 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial ...Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock ...

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144: 0001959173-23-003878.pdf. 0001959173-23-003878.rtf. View HTML: Aug 23, 2023: Statement of changes in beneficial ownership of securities. 4: 0001415889-23-012566.pdf. ... Please find the Certara ...Certara. Business Services · New Jersey, United States · 1,150 Employees. Certara is a drug development company that provides services and software that spans the drug development cycle from discovery to access. Certara is headquartered in Princeton, NJ with many locations across the globe. Read More. View Company Info for FreeCertara Inc Registered Shs Aktie Profil Die Certara Inc Registered Shs Aktie wird unter der ISIN US15687V1098 an den Börsen Hamburg, Berlin, NASDAQ, Bats, NASDAQ Bsc, Tradegate und Lang & Schwarz ... Real time Certara (CERT) stock price quote, stock graph, news & analysis. The estimated Net Worth of William F Feehery is at least $75.5 million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $42,281,189 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Overall, Nice Ltd (ADR) stock has a Value Score of 17, Growth Score of 97 and Quality Score of 94. Certara Inc stock has a Value Score of 14, Growth Score of 50 and Quality Score of 58. Comparing Nice Ltd (ADR) and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.

Certara's software platform Simcyp group awarded two new grants from US FDA Certara downgraded at Jefferies on growth headwinds Certara Non-GAAP EPS of $0.12 misses by $0.01, revenue of $90.45M ...

Certara is listed on the Nasdaq stock exchange under the ticker symbol “CERT.” When did Certara go public, and what was the offering price? Certara’s initial public offering was on December 11, 2020 at $23 per share.

PRINCETON, N.J., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share.Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screensAt closing, equity holders of Pinnacle 21 received approximately $250 million in cash consideration and 2,239,717 shares of Certara restricted common stock, subject to certain customary closing adjustments. The transaction is expected to be accretive to Certara’s revenue, revenue growth, and adjusted EBITDA.Matthew Walsh CERT stock SEC Form 4 insiders trading. Matthew has made over 12 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently Matthew exercised 9,067 units of CERT stock worth $135,733 on 17 May 2023.. The largest trade Matthew's ever made was exercising 102,043 units of …Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?Certara is the leading provider of model-informed drug development technology and services, as well as a best-in-class provider of regulatory science, writing, and submission management software and services. Certara’s solutions help inform the drug development and regulatory approval process and address the key efficacy, safety, …Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.Get the latest information on Certara, Inc. (CERT) stock, including its performance, outlook, earnings, dividends, and insider transactions. See how CERT stock compares to other medical AI companies and the healthcare industry.0.68%. $788.96M. Frontage Holdings Corp. -0.47%. HK$4.39B. CERT | Complete Certara Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …

Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.0.68%. $788.96M. Frontage Holdings Corp. -0.47%. HK$4.39B. CERT | Complete Certara Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …The average twelve-month price prediction for Palantir Technologies is $13.25 with a high price target of $25.00 and a low price target of $5.00. Learn more on PLTR's analyst rating history. Do Wall Street analysts like Palantir Technologies more than its competitors? Analysts like Palantir Technologies less than other Business Services …Instagram:https://instagram. charles schwab or fidelitybest small cap growth etftrading futures strategiesbest gold mining stocks Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development. appelispanw stock forecast PBF | Complete PBF Energy Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. l n c Certara Inc stock performance at a glance. Check Certara Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued.